Abstract
Previous results indicated that lymphoblastoid cell lines (LCL) with a BRCA1 mutation are hypersensitive to the chromosome-damaging effects of gamma irradiation or hydrogen peroxide as revealed by the micronucleus test. We now investigated six LCL (three with and three without a BRCA1 mutation) in more detail, to see whether LCL represent a useful model for the investigation of mechanisms responsible for the known mutagen sensitivity of lymphocytes from women carrying a BRCA1 mutation. Our results show that there is no systematic difference in radiation sensitivity between LCL with and without a BRCA1 mutation. Spontaneous and gamma radiation-induced micronucleus frequencies were in same range. Furthermore, cytotoxic effects (reduced cell proliferation, reduced viability) induced by gamma radiation were not different. The only difference found was an induction of micronuclei by 10 µM hydrogen peroxide in BRCA1 cell lines while a concentration of 20 µM hydrogen peroxide was necessary to induce micronuclei in control cells. Comet assay experiments did not reveal differences with regard to the induction and removal of primary DNA damage. Furthermore, expression of BRCA1 mRNA after gamma irradiation showed considerable variability and there was no clear difference between cell lines with and without BRCA mutation. These results indicate that LCL with a BRCA1 mutation do not generally show the same mutagen sensitivity as lymphocytes with the same BRCA1 mutation. Therefore, the use of LCL to study the mechanisms underlying mutagen sensitivity due to a heterozygous BRCA1 mutation seems to be limited.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Welcsh PL, Owens KN, King MC: Insights into the functions of BRCA1 and BRCA2. Trends Genet 16(2): 69-74, 2000
Kerr P, Ashworth A: New complexities for BRCA1 and BRCA2. Curr Biol 11: R668-R676, 2001
Ventikaraman AR: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108: 171-182, 2002
Scott D, Barber JBP, Levine EL, Burrill W, Roberts SA: Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br J Cancer 77: 614-620, 1998
Rothfuss A, Schütz P, Bochum S, Volm T, Eberhardt E, Kreienberg K, Vogel W, Speit G: Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res 60: 390-394, 2000
Trenz K, Rothfuss A, Schütz P, Speit G: Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation. Mutat Res 500: 89-96, 2002
Lavin MF, Bennett I, Ramsay J, Gardiner RA, Seymour GJ, Farrell A, Walsh M: Identification of a potentially radiosensitive subgroup among patients with breast cancer. J Natl Cancer Inst 86: 1627-1634, 1994
Birrell GW, Ramsay JR: Induction of p53 protein by gamma radiation in lymphocyte lines from breast cancer and ataxia telangiectasia patients. Br J Cancer 72: 1096-1101, 1995
Ramsay JR, Birell G: Normal tissue radiosensitivity in breast cancer patients. Int J Radiat Oncol Biol Phys 31: 339-344, 1995
Foray N, Randrianarison V, Marot D, Perricaudet M, Lenoir G, Feunteun J: Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene 18: 7334-7342, 1999
Speit G, Trenz K, Schütz P, Bendix R, Dörk T: Mutagensensitivity of human lymphoblastoid cells with a BRCA1 mutation in comparison to ataxia telangiectasia heterozygote cells. Cytogenet Cell Genet 91: 261-266, 2000
Speit G, Hartmann A: The comet assay (single-cell gel test). In: Henderson DS (ed) Methods in Molecular Biology. DNA Repair Protocols: Eukaryotic Systems. Vol 113 Humana Press, Totowa, 1999, pp. 203-212
Gazdar AF, Kurvari V, Virmani A, Gollahon L, Sakaguchi M, Westerfield M, Kodagoda D, Stasny V, Cunningham HT, Wistuba II, Tomlinson G, Vijay T, Ashfaq R, Leitch AM, Minna JD, Shay JW: Characterisation of paired tumor and non-tumor cell lines established from patients with breast cancer. Int J Cancer 78: 766-774, 1998
Scully R, Ganesan S, Vlasakova K, Chen J, Socolovsky M, Livingston DM: Genetic analysis of BRCA1 function in a defined tumor cell line. Mol Cell 4: 1093-1099, 1999
Abbott DW, Thompson ME, Robinson-Benion C, Tomlinson G, Jensen RA, Holt JT: BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J Biol Chem 274: 18808-18812, 1999
Wang H, Zeng Z, Bui T, Dibiase SJ, Qin W, Xia F, Powell SN, Iliakis G: Nonhomologous End-Joining of ionising radiationinduced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2. Cancer Res 61: 270-277, 2001
Jaloszynski P, Kujawski M, Czub-Swierczek M, Markowska J, Szyfter K: Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assay. Mutat Res 385: 223-233, 1997
McKelvey-Martin VJ, Ho ETS, McKeown SR, Johnston SR, McCarthy PJ, Downes CS: Emerging applications of the single cell gel electrophoresis (comet) assay. I. Management of invasive transitional cell human bladder carcinoma. II. Fluorescent in situ hybridisation comets for the identification of damaged and repaired DNA sequences in individual cells. Mutagenesis 13: 1-8, 1998
Alapetite C, Thrion P, Rochefordière A, Cosset J, Moustacchi E: Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients. Int J Cancer 83: 83-90, 1999
Schmezer P, Rajaee-Behbahani N, Risch A, Thiel S, Rittgen W, Drings P, Dienemann H, Kayser KW, Schulz V, Bartsch H: Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes. Mutagenesis 16: 25-30, 2001
Price ME, McKelvey-Martin VJ, Robson T, Hirst DG, McKeown: Induction and rejoining of DNA double-strand breaks in bladder tumor cells. Radiat Res 153: 788-794, 2000
Ribieras S, Magdinier F, Leclerc D, Lenoir G, Frappart L, Dante R: Abundance of BRCA1 transcripts in human cancer and lymphoblastoid cell lines carrying BRCA1 germ-line alterations. Int J Cancer 73: 715-718, 1997
Andres JL, Fan S, Turkel GJ, Wang J, Twu N, Yuan R, Lamszus K, Goldberg ID, Rosen EM: Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Oncogene 16: 2229-2241, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Trenz, K., Landgraf, J. & Speit, G. Mutagen Sensitivity of Human Lymphoblastoid Cells with a BRCA1 Mutation. Breast Cancer Res Treat 78, 69–79 (2003). https://doi.org/10.1023/A:1022157528247
Issue Date:
DOI: https://doi.org/10.1023/A:1022157528247